US Patent Issued to Navigo Proteins on Dec. 30 for "FOLR1 specific binding proteins for cancer diagnosis and treatment" (German Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,493, issued on Dec. 30, was assigned to Navigo Proteins GmbH (Halle/Saale, Germany).

"FOLR1 specific binding proteins for cancer diagnosis and treatment" was invented by Erik Fiedler (Halle/Saale, Germany), Ulrich Haupts (Halle/Saale, Germany), Manja Gloser-Braunig (Halle/Saale, Germany) and Eva Bosse-Doenecke (Halle/Saale, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new binding proteins that are specific for folate receptor alpha (FOLR1). The invention further refers to FOLR1 binding proteins that further comprises a diagnostically or therapeutically active component. Further aspects of the invention cove...